Mimis And Trems: Innovation In Male Reproductive Medicine And Surgery. Multi-Centric Clinical Trials In Low Cost Clinical Hubs

In the last COGI Congresses in Paris (Paris, France, November 17-20, 2011, A6), in Hainan (Hainan, China, December 8-11, 2011, A27) and in Singapore (Singapore, July 19-22, 2012), the principles of MARS - Male Reproductive Surgery and MicroSurgery have been described in their fundamentals, based on the historical issues and on the new collective intelligence and knowledge in implementing Innovation technologies in Human Reproduction and Family Welfare.How Male Reproductive Surgery -MaRS preserves or enhances Fertility is strictly dependent on the holistic approach of the Fertility of Couple and on the dedicated Technologies supporting Techniques implemented on (TREMS).The new MIMIS Techniques, called MIVAS, MIRES, IRMIS, TAS, MIRMAC, have been applied through a pilot multi-centric trial with a monitoring period of three years in so-called low and intermediate cost MIR Hubs in Italy, Hungary and Albania, to demonstrate the potential widespread application of MIMIS supported by high technological content -to preserve, restore and enhance Male Fertility Power -.MIVAS - Male Infertility Vascular Surgery, MIRES - Male Infertility Reconstructive Surgery, IRMIS - Infra Red Male Infertility Surgery, TAS - Testis Augmentation Surgery, MIRMAC -Microsurgery Reversible Male Contraception based on RISUG Adv. represent the Core of new Microsurgical Techniques supported by Innovative Technologies for Surgery and Male Factor.The Global Evaluation has been scored in terms of Learning Curve Surgical Training (LEC) for the Microsurgical Operator, Impact on the Male Factor (IMF) and Cost-Benefit Ratio (C/B). Surgical Expertise and Skillfullness, Clinically Evaluable Male Factor Restoration and Improvement and Social Economy Benefit are reported comparing and addressing Human Reproduction and Family Welfare Policies.